Cargando…

Telomere Shortening Is behind the Harm of Immunosuppressive Therapy in Idiopathic Pulmonary Fibrosis

Detalles Bibliográficos
Autor principal:	Molina-Molina, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2019
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680301/ https://www.ncbi.nlm.nih.gov/pubmed/30624965 http://dx.doi.org/10.1164/rccm.201812-2330ED

Ejemplares similares

Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease
por: Zhang, David, et al.
Publicado: (2023)

Idiopathic Pulmonary Fibrosis and Telomeres
por: Mulet, Alba, et al.
Publicado: (2022)

Telomere Dysfunction in Idiopathic Pulmonary Fibrosis
por: Zhang, Kexiong, et al.
Publicado: (2021)

Telomere Abnormalities in the Pathobiology of Idiopathic Pulmonary Fibrosis
por: Bilgili, Hasancan, et al.
Publicado: (2019)

Asynchronous Shortening of Telomere Length and Cardiovascular Outcomes
por: Wang, Chao-Yung
Publicado: (2018)

Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients
por: Suarez-Cuartin, Guillermo, et al.
Publicado: (2020)

Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
por: Suarez-Cuartin, Guillermo, et al.
Publicado: (2019)

Exome Sequencing Links Mutations in PARN and RTEL1 with Familial Pulmonary Fibrosis and Telomere Shortening
por: Stuart, Bridget D., et al.
Publicado: (2015)

Idiopathic pulmonary fibrosis and the role of genetics in the era of precision medicine
por: Alonso-Gonzalez, Aitana, et al.
Publicado: (2023)

Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis
por: Machahua, Carlos, et al.
Publicado: (2016)

Osteoarthritis and telomere shortening
por: Kuszel, Lukasz, et al.
Publicado: (2014)

Idiopathic pulmonary fibrosis: moving forward
por: Richeldi, Luca
Publicado: (2015)

State of the Art in Idiopathic Pulmonary Fibrosis
por: El Agha, Elie, et al.
Publicado: (2022)

The Role of Surgical Lung Biopsy in Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
por: Limper, Andrew H.
Publicado: (2019)

Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis
por: Machahua, Carlos, et al.
Publicado: (2018)

Autophagy in Idiopathic Pulmonary Fibrosis: Predisposition of the Aging Lung to Fibrosis?
por: Zmijewski, Jaroslaw W., et al.
Publicado: (2022)

Accelerated Telomere Shortening in Acromegaly; IGF-I Induces Telomere Shortening and Cellular Senescence
por: Matsumoto, Ryusaku, et al.
Publicado: (2015)

The JAK2 pathway is activated in idiopathic pulmonary fibrosis
por: Milara, Javier, et al.
Publicado: (2018)

A role for telomere length and chromosomal damage in idiopathic pulmonary fibrosis
por: McDonough, John E., et al.
Publicado: (2018)

Telomere dysfunction implicates POT1 in patients with idiopathic pulmonary fibrosis
por: Kelich, Joseph, et al.
Publicado: (2022)

Toward Early Detection of Idiopathic Pulmonary Fibrosis
por: Schupp, Jonas Christian, et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis management: caring is sparing
por: Nava, Stefano, et al.
Publicado: (2020)

Revisiting Telomere Shortening in Cancer
por: Okamoto, Keiji, et al.
Publicado: (2019)

Genetic analyses of aplastic anemia and idiopathic pulmonary fibrosis patients with short telomeres, possible implication of DNA-repair genes
por: Arias-Salgado, Elena G., et al.
Publicado: (2019)

Oxidative Stress, Telomere Shortening, and Apoptosis Associated to Sarcopenia and Frailty in Patients with Multimorbidity
por: Bernabeu-Wittel, Máximo, et al.
Publicado: (2020)

ATP12A: Connecting Mucus and Fibrosis in Idiopathic Pulmonary Fibrosis
por: Zabner, Joseph, et al.
Publicado: (2023)

Ironing Out the Roles of Macrophages in Idiopathic Pulmonary Fibrosis
por: O’Dwyer, David N., et al.
Publicado: (2019)

Another Weapon in the Battle against Idiopathic Pulmonary Fibrosis?
por: Wilson, Carole L., et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis: accurate diagnosis and early treatment
por: Morais, António
Publicado: (2019)

Guidelines or guidance for better idiopathic pulmonary fibrosis management?
por: Behr, Jürgen
Publicado: (2016)

Small Airways in Idiopathic Pulmonary Fibrosis: Quiet but Not Forgotten
por: Maher, Toby M.
Publicado: (2021)

Chronic Cough in Idiopathic Pulmonary Fibrosis: The Same Difference?
por: Morice, Alyn H.
Publicado: (2022)

Telomere Shortening in Blood Leukocytes of Patients with Chronic Obstructive Pulmonary Disease
por: Sadr, Makan, et al.
Publicado: (2015)

Identification of MMP28 as a biomarker for the differential diagnosis of idiopathic pulmonary fibrosis
por: Maldonado, Mariel, et al.
Publicado: (2018)

Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: a case report
por: Cerri, Stefania, et al.
Publicado: (2016)

Predictors and changes of physical activity in idiopathic pulmonary fibrosis
por: Badenes-Bonet, Diana, et al.
Publicado: (2022)

Changes in serum metabolomics in idiopathic pulmonary fibrosis and effect of approved antifibrotic medication
por: Seeliger, Benjamin, et al.
Publicado: (2022)

Telomere shortening and telomere position effect in mild ring 17 syndrome
por: Surace, Cecilia, et al.
Publicado: (2014)

Telomere shortening in leukocyte subpopulations in depression
por: Karabatsiakis, Alexander, et al.
Publicado: (2014)

The Importance of Telomere Shortening for Atherosclerosis and Mortality
por: Herrmann, Wolfgang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o0uns1rqfo7k7af8drlfm7b674